• +1-646-491-9876
    • +91-20-67278686

    Search

    West Nile Virus Infections - Pipeline Review, H1 2017

    West Nile Virus Infections - Pipeline Review, H1 2017

    • Report Code ID: RW0001767488
    • Category Pharmaceuticals
    • No. of Pages 67
    • Publication Month Apr-17
    • Publisher Name Global Markets Direct
    West Nile Virus Infections - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide West Nile Virus Infections - Pipeline Review, H1 2017, provides an overview of the West Nile Virus Infections (Infectious Disease) pipeline landscape.

    West Nile infection is caused by a virus transmitted by mosquitoes. The West Nile virus is a type of virus known as a Flavivirus. Symptoms include a fever, headache, body aches, skin rash, and swollen lymph glands. Risk factors for developing a more severe form of West Nile virus include conditions that weaken the immune system, such as HIV, organ transplants, and recent chemotherapy, age and pregnancy.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide West Nile Virus Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for West Nile Virus Infections (Infectious Disease) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I, Preclinical and Discovery stages are 3, 8 and 2 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 3 and 3 molecules, respectively.

    West Nile Virus Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of West Nile Virus Infections (Infectious Disease) .
    - The pipeline guide reviews pipeline therapeutics for West Nile Virus Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in West Nile Virus Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates West Nile Virus Infections (Infectious Disease) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for West Nile Virus Infections (Infectious Disease)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for West Nile Virus Infections (Infectious Disease) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding West Nile Virus Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    West Nile Virus Infections - Overview
    West Nile Virus Infections - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    West Nile Virus Infections - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    West Nile Virus Infections - Companies Involved in Therapeutics Development
    CEL-SCI Corp
    Fab'entech SA
    Hemispherx Biopharma Inc
    Kineta Inc
    Nanotherapeutics Inc
    Plex Pharmaceuticals Inc
    Theravectys SA
    West Nile Virus Infections - Drug Profiles
    AGS-v - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Alferon LDO - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    BG-323 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CEL-1000 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    FDX-000 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    HydroVax-001 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    interferon alfa-n3 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    KIN-1148 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    KIN-1400 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Monoclonal Antibody for West Nile Virus Infections - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    rintatolimod - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecule to Inhibit NS2B-NS3 Protease for Dengue, Zika and West Nile Virus Infection - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules for Viral Infections - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules to Inhibit NS3 Protease for Dengue and West Nile Virus Infections - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecules to Inhibit NS5 for Japanese Encephalitis and Viral Infections - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Synthetic Peptide for Dengue Virus and West Nile Virus Infections - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Tatbeclin-1 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    West Nile virus vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    West Nile virus vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    West Nile virus vaccine - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    West Nile Virus Infections - Dormant Projects
    West Nile Virus Infections - Product Development Milestones
    Featured News & Press Releases
    Feb 21, 2017: hVIVO notes the initiation of a Phase I clinical trial with AGS-v, a mosquito-borne disease vaccine candidate
    Jul 06, 2015: NIH-funded vaccine for West Nile Virus enters human clinical trials
    May 05, 2014: Alferon N Effective Against MERS Virus In-Vitro
    Sep 12, 2013: Hemispherx Announces Initial Test Results in Biosecurity/Biodefense Arena
    Sep 06, 2011: Hemispherx Enters Into Strategic Alliance With Armada Health Care For Alferon N Injection
    Apr 20, 2010: Kineta Scientist to Present Novel Antiviral Research Findings at International Conference
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for West Nile Virus Infections, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    West Nile Virus Infections - Pipeline by CEL-SCI Corp, H1 2017
    West Nile Virus Infections - Pipeline by Fab'entech SA, H1 2017
    West Nile Virus Infections - Pipeline by Hemispherx Biopharma Inc, H1 2017
    West Nile Virus Infections - Pipeline by Kineta Inc, H1 2017
    West Nile Virus Infections - Pipeline by Nanotherapeutics Inc, H1 2017
    West Nile Virus Infections - Pipeline by Plex Pharmaceuticals Inc, H1 2017
    West Nile Virus Infections - Pipeline by Theravectys SA, H1 2017
    West Nile Virus Infections - Dormant Projects, H1 2017
    West Nile Virus Infections - Dormant Projects, H1 2017 (Contd..1) , H1 2017

    List of Figures

    Number of Products under Development for West Nile Virus Infections, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Top 10 Molecule Types, H1 2017
    Number of Products by Stage and Top 10 Molecule Types, H1 2017
    CEL-SCI Corp
    Fab'entech SA
    Hemispherx Biopharma Inc
    Kineta Inc
    Nanotherapeutics Inc
    Plex Pharmaceuticals Inc
    Theravectys SA

    Request for Sample

    Report Url http://www.reportsweb.com//west-nile-virus-infections-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//west-nile-virus-infections-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//west-nile-virus-infections-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments